Browsing Over 32 Presentations
Sort By
Keynote lecture (ID 2)
Keynote lecture
The cell cycle regulation and biological basis of CDK inhibition (ID 1)
Lecture Time
11:45 - 12:05
Speakers
- Marcos Malumbres (Madrid, ES)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
11:45 - 12:30
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Educational session
Are all CDK 4-6 created equal? (ID 31)
Lecture Time
14:30 - 14:50
Speakers
- Giuseppe Curigliano (Milan, IT)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
The disappointing results of initial CDKI and their role in other disease (ID 7)
Educational session
Q&A (ID 26)
Lecture Time
12:25 - 12:40
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
11:10 - 12:40
Interaction between CDKs, CDKI and other targets (ID 6)
Educational session
MEK (ID 20)
Lecture Time
10:00 - 10:20
Speakers
- Olivier Michielin (Lausanne, CH)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Preclinical evidence of efficacy (ID 5)
Educational session
Comparison of preclinical data across CDK 4-6 (ID 15)
Lecture Time
17:40 - 18:00
Speakers
- Romano Danesi (Pisa, IT)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Educational session
DNA damage and checkpoint kinases (ID 10)
Lecture Time
15:30 - 15:50
Speakers
- Fabrizio D'Adda di Fagagna (Milan, IT)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
The role of CDK along the mitotic process in normal and pathological condition (ID 3)
Educational session
The biology of the CDK4–CDK6–RB pathway (ID 5)
Lecture Time
13:40 - 14:00
Speakers
- Tobias Otto (Aachen, DE)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
13:20 - 14:30
The concept of CDK inhibition according to the targeted CDK subtype (ID 4)
Educational session
Mechanism of resistance to CDKs inhibitors (ID 33)
Lecture Time
15:50 - 16:10
Speakers
- Giulio Draetta (Houston, US)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
14:30 - 16:20
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Educational session
Palbociclib (ID 28)
Lecture Time
13:30 - 13:50
Speakers
- Javier Cortes (Madrid, ES)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
Interaction between CDKs, CDKI and other targets (ID 6)
Educational session
Q&A (ID 22)
Lecture Time
10:40 - 10:50
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Interaction between CDKs, CDKI and other targets (ID 6)
Educational session
Synthetic lethality (ID 17)
Lecture Time
09:00 - 09:20
Speakers
- Rene Bernards (Amsterdam, NL)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
09:00 - 10:50
Preclinical evidence of efficacy (ID 5)
Educational session
Preclinical evidence of activity of palbociclib (ID 12)
Lecture Time
16:40 - 17:00
Speakers
- Angel Guerrero (Valencia, ES)
Session Name
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
23.03.2018
Time
16:40 - 18:10